Factory Supply High Quality 99% Raw Material Meloxicam Powder CAS 71125-38-7
Product Description
Top Quality Meloxicam For Arthritis Anti-inflammatory CAS 71125-38-7
Product name: Meloxicam
Synonyms: metacam; mobic
MOQ: 1kg
CAS No.:71125-38-7
Appearance: Yellow powder
Molecular Formula: C14H13N3O4S2
Molecular Weight: 351.40
Assay: 98.0%~102.0%
Application: Pharma grade
Packing: As per your request
MOQ: 1kg
CAS No.:71125-38-7
Appearance: Yellow powder
Molecular Formula: C14H13N3O4S2
Molecular Weight: 351.40
Assay: 98.0%~102.0%
Application: Pharma grade
Packing: As per your request
Storage: Preserve in tight,light-resistant containers in a cool place
Function:
Older patients and patients with an increased risk of adverse reactions;
In elderly patients, patients with rheumatoid arthritis and ankylosing spondylitis treatment recommended dose for 7.5mg/days. Starting dose in patients with increased risk of adverse reactions to 7.5mg/days.
Patients with renal insufficiency:
Patients with severe renal failure and need dialysis, the dose should not exceed 7.5mg/days.
Patients with mild to moderate renal insufficiency do not need to adjust the dosage (such as patients with creatinine clearance greater than 25ml/minutes).
Patients with severe renal failure without dialysis, see [taboo].
Patients with hepatic insufficiency: In patients with mild and moderate hepatic insufficiency no need to adjust the dose. In patients with severe hepatic insufficiency, see [taboo].
Children: This product is not for use in children under 15 years of age. Meloxicam has other forms, may apply.
In elderly patients, patients with rheumatoid arthritis and ankylosing spondylitis treatment recommended dose for 7.5mg/days. Starting dose in patients with increased risk of adverse reactions to 7.5mg/days.
Patients with renal insufficiency:
Patients with severe renal failure and need dialysis, the dose should not exceed 7.5mg/days.
Patients with mild to moderate renal insufficiency do not need to adjust the dosage (such as patients with creatinine clearance greater than 25ml/minutes).
Patients with severe renal failure without dialysis, see [taboo].
Patients with hepatic insufficiency: In patients with mild and moderate hepatic insufficiency no need to adjust the dose. In patients with severe hepatic insufficiency, see [taboo].
Children: This product is not for use in children under 15 years of age. Meloxicam has other forms, may apply.
Packing and Shipping: